| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |